Both in Biotechnology
Moderna vs Neurocrine Biosciences
Over the past year MRNA returned +817.1% and NBIX returned +16.1%; their daily moves had a correlation of 0.17.
MRNA +817.1% NBIX +16.1%Growth of $1, one year, split-adjusted
| Metric | MRNA | NBIX |
|---|---|---|
| Price | $228.44 | $164.85 |
| Market cap | $91.20B | $16.76B |
| Today | +3.45% | +13.42% |
| 1 month | +12.4% | +14.3% |
| 6 months | +389.1% | +22.1% |
| Year to date | +674.6% | +16.2% |
| 1 year | +741.1% | +15.1% |
| Revenue growth (YoY) | +2.1% | +41.2% |
| Gross margin | 35.9% | 97.6% |
| Net margin | −539.3% | 18.4% |
| P/E (TTM) | — | 23.9× |
| Price / sales | 40.9× | 4.5× |
| Net cash | $4.54B | $737.9M |
| Dividend yield | — | — |
| Volatility (60d) | 230.1% | 36.6% |
| Short % of float | 9.0% | 6.6% |
| Next earnings | Nov 6, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).